Impedimed Ltd has released a press release.
Appendix 4C - Quarter ended 31 March 2019
Filed with ASX ·
Watch Impedimed's latest callImpedimed (ASX:IPD) Q1 2027 Earnings Call · Replay · Oct 29Read the transcript of Impedimed (ASX:IPD) Q1 2027 Earnings Call6ix hasn’t read this filing yet.
Earlier from Impedimed
- US Investor Presentation
- S&P DJI Announces March 2019 Quarterly Rebalance
- Appendix 4C - Quarter ended 31 December 2018
- PREVENT Trial accepted for Publication and Presentation
- Ascension National Purchasing Agreement Received
Later from Impedimed
- ASBrS Releases PREVENT Abstract
- PREVENT Interim Results - Practice-Changing
- A$13.9m Fully Underwritten Entitlement Offer Announced
- Offer Booklet - Entitlement Offer
- Completion of Entitlement Offer
Follow Impedimed into a list and get an email when it puts out news.
Follow Impedimed